Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: July 1, 2020
A Prospective, Controlled, Interventional Study to Evaluate the Efficacy and Safety of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
Clinical Trial
  • Status: Recruiting
  • Participants: 500
  • Start Date: March 17, 2020
National Registry of Idiopathic Retroperitoneal Fibrosis in China
Search for trials
Clinical Trial
  • Status: Recruiting
  • Participants: 500
  • Start Date: January 17, 2020
A Prospective Cohort Study of Idiopathic Retroperitoneal Fibrosis in China
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: January 3, 2020
A Prospective Study to Evaluate the Efficacy and Safety of Cyclophosphamide in the Treatment of Idiopathic Retroperitoneal Fibrosis
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: July 1, 2018
Prospective Study of Prednisone Versus Sirolimus in the Treatment of Idiopathic Retroperitoneal Fibrosis
Showing 1-5 of 5